Holen Sie sich die Stockscreener-App
41.12
1.91%
-0.80
Vorhandelsmarkt:
39.67
-1.45
-3.53%
Schlusskurs vom Vortag:
$41.92
Offen:
$41.6
24-Stunden-Volumen:
1.11M
Relative Volume:
1.34
Marktkapitalisierung:
$3.17B
Einnahmen:
$13.17M
Nettoeinkommen (Verlust:
$-199.06M
KGV:
-15.01
EPS:
-2.74
Netto-Cashflow:
$-156.53M
1W Leistung:
-1.84%
1M Leistung:
+3.81%
6M Leistung:
+7.42%
1J Leistung:
-1.37%
1-Tages-Spanne:
$40.13
$41.70
1-Wochen-Bereich:
$40.13
$42.96
52-Wochen-Spanne:
$26.74
$46.00
Xenon Pharmaceuticals Inc Stock (XENE) Company Profile
Firmenname
Xenon Pharmaceuticals Inc
Sektor
Branche
Telefon
(604) 484-3300
Adresse
200 - 3650 GILMORE WAY, BURNABY
Vergleichen Sie XENE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XENE
Xenon Pharmaceuticals Inc
|
41.12 | 3.23B | 13.17M | -199.06M | -156.53M | -2.74 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Fortgesetzt | Wells Fargo | Overweight |
| 2025-05-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-10-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-01-04 | Eingeleitet | Citigroup | Buy |
| 2023-12-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2023-04-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-14 | Eingeleitet | Goldman | Buy |
| 2022-12-12 | Eingeleitet | Cowen | Outperform |
| 2022-11-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-19 | Eingeleitet | Raymond James | Outperform |
| 2022-08-29 | Eingeleitet | BofA Securities | Buy |
| 2022-07-21 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-28 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-10-02 | Eingeleitet | SVB Leerink | Outperform |
| 2020-07-21 | Eingeleitet | Needham | Buy |
| 2020-06-01 | Fortgesetzt | Jefferies | Buy |
| 2020-03-25 | Eingeleitet | Wedbush | Outperform |
| 2020-01-08 | Eingeleitet | William Blair | Outperform |
| 2019-09-20 | Eingeleitet | Guggenheim | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2017-03-13 | Eingeleitet | Jefferies | Buy |
| 2016-10-21 | Eingeleitet | Stifel | Buy |
| 2016-09-26 | Eingeleitet | Guggenheim | Buy |
| 2016-04-14 | Bestätigt | Jefferies | Buy |
| 2015-10-30 | Fortgesetzt | Jefferies | Buy |
| 2014-12-02 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Xenon Pharmaceuticals Inc Aktie (XENE) Neueste Nachrichten
XENE: Needham Reiterates Buy Rating with Price Target of $55.00 - GuruFocus
Short interest data insights for Xenon Pharmaceuticals Inc.Market Sentiment Summary & Precise Swing Trade Alerts - newser.com
Why Xenon Pharmaceuticals Inc. stock could outperform in 2025Weekly Trade Recap & Consistent Income Trade Recommendations - newser.com
Chart overlay techniques for tracking Xenon Pharmaceuticals Inc.July 2025 Recap & Capital Efficiency Focused Ideas - newser.com
Xenon Pharmaceuticals Inc (XENE) Q3 2025 Earnings Call Highlight - GuruFocus
Xenon Pharmaceuticals Inc (XENE) Q3 2025 Earnings Call Highlights: Strong Financial Position ... - Yahoo Finance
Xenon Pharmaceuticals Reports Q3 2025 Financial Results - TipRanks
How strong is Xenon Pharmaceuticals Inc. stock revenue growth2025 Winners & Losers & Low Risk Investment Opportunities - newser.com
Earnings call transcript: Xenon Pharmaceuticals Q3 2025 sees steady cash reserves - Investing.com
Earnings Flash (XENE) Xenon Pharmaceuticals Posts Q3 EPS $-1.15, vs. FactSet Est of $-1.15 - MarketScreener
XENE Financial Position Update: Cash Holdings Decline - GuruFocus
Xenon Reports Q3 2025 Financial Results and Progress - TipRanks
Xenon Pharmaceuticals: Q3 Earnings Snapshot - KVUE
Xenon Pharmaceuticals Inc. SEC 10-Q Report - TradingView
Xenon Pharmaceuticals Keeps R&D Rolling While Analysts Stay Bullish - Finimize
Xenon Reports Third Quarter 2025 Financial Results & Business Update - The Manila Times
Xenon Pharmaceuticals Q3 net loss beats expectations - MarketScreener
When is the best time to exit Xenon Pharmaceuticals Inc.Portfolio Update Summary & Target Return Focused Stock Picks - newser.com
Will Xenon Pharmaceuticals Inc. price bounce be sustainableInsider Buying & Expert Verified Stock Movement Alerts - newser.com
What MACD and RSI say about Xenon Pharmaceuticals Inc.2025 Earnings Impact & Weekly Market Pulse Updates - newser.com
Can Xenon Pharmaceuticals Inc. stock deliver sustainable ROEWeekly Stock Analysis & AI Based Trade Execution Alerts - newser.com
Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees - MSN
Why Xenon Pharmaceuticals Inc. stock is trending among retail tradersQuarterly Performance Summary & Reliable Price Breakout Signals - newser.com
Using Ichimoku Cloud for Xenon Pharmaceuticals Inc. technicalsIndex Update & Fast Momentum Entry Tips - newser.com
Tools to monitor Xenon Pharmaceuticals Inc. recovery probabilityQuarterly Profit Review & Real-Time Buy Signal Alerts - newser.com
Technical signs of recovery in Xenon Pharmaceuticals Inc.Recession Risk & Weekly High Potential Alerts - newser.com
What valuation multiples suggest for Xenon Pharmaceuticals Inc. stock - newser.com
State of New Jersey Common Pension Fund D Increases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Pharmaceuticals Inc. $XENE Position Trimmed by Jennison Associates LLC - MarketBeat
Will Xenon Pharmaceuticals Inc. stock continue dividend increasesJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Traders Buy High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE) - MarketBeat
Intraday pattern recognizer results for Xenon Pharmaceuticals Inc.July 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Xenon Pharmaceuticals Inc. (XENE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Xenon Pharmaceuticals Inc. (XENE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Xenon Pharmaceuticals (XENE) Expected to Announce Earnings on Monday - MarketBeat
Finanzdaten der Xenon Pharmaceuticals Inc-Aktie (XENE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):